CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 700 shares at $21.38 ($14,966)
- 4 Open-market sale General Counsel sold 255 shares at $21.38 ($5,452)
- 4 Open-market sale Chief Financial Officer sold 135 shares at $21.41 ($2,890)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 735 shares at $3.38 ($2,484)
- 4 Open-market sale General Counsel sold 260 shares at $3.39 ($881)
- 4 Open-market sale Interim CFO sold 147 shares at $3.39 ($498)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 471 shares at $5.60 ($2,638)
- 4 Open-market sale Interim CFO sold 261 shares at $5.63 ($1,469)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 1,341 shares at $5.60 ($7,510)
Page 2 of 7 · 135 filings